How Is a Pulmonary Embolism Treated? (TRT Q&As)
Timeline
Dr. O’Connor explains that treatment depends on the size of the clot and the patient’s stability. In his case, doctors used heparin and then Xarelto rather than mechanically removing the clot because his heart remained stable and the clots could be managed with anticoagulation.
The caller says his blood pressure rose after starting testosterone but improved after significant weight loss. Dr. O’Connor discusses telmisartan, tadalafil, and other cardiovascular medications as tools that may help control blood pressure and improve vascular health when used appropriately.
The caller asks whether newer data have changed Dr. O’Connor’s opinion on RAD-140 and MK-677. Dr. O’Connor warns that RAD-140 has been associated with significant liver toxicity in case reports and says SARMs and secretagogues remain difficult to evaluate because of limited long-term data, cardiovascular concerns, and uncertainty about product quality.
The caller says he has read claims that RAD-140 may reduce prostate size. Dr. O’Connor strongly rejects that claim, saying there is no convincing basis for treating RAD-140 as a prostate-shrinking therapy and warning against relying on that kind of information.
The discussion turns to a member who switched from amlodipine to telmisartan and nebivolol. Dr. O’Connor supports individualized blood pressure treatment and emphasizes monitoring response, tolerability, cardiovascular health, and other ABCD risk factors rather than relying on a single medication approach.
Video Summary
Participants ask about testosterone therapy outcomes and what changes in symptoms actually mean. The answers connect dosing and injection details to how response is felt across energy, libido, and sexual function. Blood pressure is raised as a health context that shapes how treatment decisions are framed. The clinician emphasizes interpreting patterns rather than chasing a single day of improvement or decline.
Questions about erectile dysfunction bring tadalafil and sildenafil into the conversation as supportive medications. The discussion explains how these medications are considered alongside testosterone therapy instead of being treated as the only solution. Side effects are addressed when they are mentioned, with attention to what the person is experiencing rather than generic warnings. The thread throughout is to match the plan to the reported symptoms and the overall response.
Follow-up planning returns to what to monitor, including blood pressure and ongoing symptom shifts. The clinician reinforces that clear descriptions help determine whether dosing or timing should change. Erectile dysfunction concerns are revisited when participants describe persistence or variability. The session closes with practical guidance on what to track so future adjustments are based on concrete observations.
Drug Callouts
Condition Callouts
Key Takeaways
- Testosterone follow-up decisions are framed around symptom patterns, libido, and sexual function rather than one-off impressions.
- Dosing and injections are discussed as practical levers that can change how response is experienced across time.
- Blood pressure and hypertension are treated as important context that shapes monitoring and the overall treatment approach.
- Erectile dysfunction questions introduce tadalafil and sildenafil, with emphasis on how medication choices fit into the broader plan.
- Side effects and symptoms are addressed by focusing on what is reported clearly, so adjustments are grounded in concrete observations.